Albuquerque, New Mexico — According to state and local economic development sources BioDirection plans to build out 9,000 square feet of new space in Albuquerque. The company plans to occupy the new space in Albuquerque, on or about June 1, 2020. According to the company website BioDirection, Inc. is a privately held medical device company developing novel and rapid point-of-care technologies for the objective diagnosis and management of concussion and other traumatic brain injury (TBI). The company’s lead product, the Tbit blood test, delivers biologically based results shown to confirm a concussion accurately in less than 90 seconds. BioDirection’s platform utilizes a patented bio-nanowire technology with the potential for use in a range of applications in point-of-care diagnostics.

To learn more about BioDirection, visit http://biodirection.com/

Company Contact:
Sharad Joshi, Chief Executive Officer
sharad@biodirection.com
508-599-2400

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved